{
    "organizations": [],
    "uuid": "20d487683c7c8deff77e0d041bba936c6e37cf8c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-egypts-october-pharma-fy-profit-ri/brief-egypts-october-pharma-fy-profit-rises-idUSFWN1Q90B5",
    "ord_in_thread": 0,
    "title": "BRIEF-Egypt's October Pharma FY Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 19 (Reuters) - OCTOBER PHARMA FOR PHARMACEUTICAL INDUSTRIES:\n* FY NET PROFIT AFTER TAX EGP 56 ‍​MILLION VERSUS EGP 35 ‍​MILLION YEAR AGO\n* BOARD PROPOSES FY CASH DIVIDEND OF EGP 4 PER SHARE * FY SALES EGP 350 MILLION VERSUS EGP 288 MILLION YEAR AGO * BOARD GIVES INITIAL APPROVAL TO ESTABLISH LEGAL ENTITY IN UAE‍​ Source:( bit.ly/2FfGCJO ) Further company coverage:\n ",
    "published": "2018-02-19T18:41:00.000+02:00",
    "crawled": "2018-02-20T14:24:55.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "october",
        "pharma",
        "pharmaceutical",
        "industry",
        "fy",
        "net",
        "profit",
        "tax",
        "egp",
        "versus",
        "egp",
        "year",
        "ago",
        "board",
        "proposes",
        "fy",
        "cash",
        "dividend",
        "egp",
        "per",
        "share",
        "fy",
        "sale",
        "egp",
        "million",
        "versus",
        "egp",
        "million",
        "year",
        "ago",
        "board",
        "give",
        "initial",
        "approval",
        "establish",
        "legal",
        "entity",
        "source",
        "company",
        "coverage"
    ]
}